Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 27

    1.

    Clinical performance of the TRUE2go blood glucose system--a novel integrated system for meter and strips.

    Kipnes MS, Joseph H, Morris H, Manko J, Bell DE.

    Diabetes Technol Ther. 2009 Oct;11(10):649-55.PMID: 19821757 [PubMed - in process]Related articles

    2.

    Safety and effectiveness of Realize adjustable gastric band: 3-year prospective study in the United States.

    Phillips E, Ponce J, Cunneen SA, Bhoyrul S, Gomez E, Ikramuddin S, Jacobs M, Kipnes M, Martin L, Marema RT, Pilcher J, Rosenthal R, Rubenstein R, Teixeira J, Trus T, Zundel N.

    Surg Obes Relat Dis. 2009 Sep-Oct;5(5):588-97. Epub 2009 Jan 18.PMID: 19342314 [PubMed - in process]Related articles

    3.

    Dapagliflozin: an emerging treatment option in type 2 diabetes.

    Kipnes M.

    Expert Opin Investig Drugs. 2009 Mar;18(3):327-34. Review.PMID: 19243283 [PubMed - indexed for MEDLINE]Related articles

    4.

    Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy.

    Pratley RE, Kipnes MS, Fleck PR, Wilson C, Mekki Q; Alogliptin Study 007 Group.

    Diabetes Obes Metab. 2009 Feb;11(2):167-76.PMID: 19125778 [PubMed - indexed for MEDLINE]Related articles

    5.

    Evaluation of various doses of recombinant human thyrotropin in patients with multinodular goiters.

    Braverman L, Kloos RT, Law B Jr, Kipnes M, Dionne M, Magner J.

    Endocr Pract. 2008 Oct;14(7):832-9.PMID: 18996810 [PubMed - indexed for MEDLINE]Related articles

    6.

    Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.

    Hermansen K, Kipnes M, Luo E, Fanurik D, Khatami H, Stein P; Sitagliptin Study 035 Group.

    Diabetes Obes Metab. 2007 Sep;9(5):733-45. Epub 2007 Jun 26.PMID: 17593236 [PubMed - indexed for MEDLINE]Related articles

    7.

    Sitagliptin: a viewpoint by Mark S. Kipnes.

    Kipnes MS.

    Drugs. 2007;67(4):598-9. No abstract available. PMID: 17352517 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes.

    Aschner P, Kipnes MS, Lunceford JK, Sanchez M, Mickel C, Williams-Herman DE; Sitagliptin Study 021 Group.

    Diabetes Care. 2006 Dec;29(12):2632-7.PMID: 17130196 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome.

    Bakris G, Molitch M, Hewkin A, Kipnes M, Sarafidis P, Fakouhi K, Bacher P, Sowers J; STAR Investigators.

    Diabetes Care. 2006 Dec;29(12):2592-7. Erratum in: Diabetes Care. 2007 May;30(5):1329. PMID: 17130190 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes.

    Herman GA, Bergman A, Yi B, Kipnes M; Sitagliptin Study 012 Group.

    Curr Med Res Opin. 2006 Oct;22(10):1939-47.PMID: 17022853 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes.

    Herman GA, Bergman A, Stevens C, Kotey P, Yi B, Zhao P, Dietrich B, Golor G, Schrodter A, Keymeulen B, Lasseter KC, Kipnes MS, Snyder K, Hilliard D, Tanen M, Cilissen C, De Smet M, de Lepeleire I, Van Dyck K, Wang AQ, Zeng W, Davies MJ, Tanaka W, Holst JJ, Deacon CF, Gottesdiener KM, Wagner JA.

    J Clin Endocrinol Metab. 2006 Nov;91(11):4612-9. Epub 2006 Aug 15.PMID: 16912128 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Effects of pioglitazone on lipid and lipoprotein profiles in patients with type 2 diabetes and dyslipidaemia after treatment conversion from rosiglitazone while continuing stable statin therapy.

    Berhanu P, Kipnes MS, Khan MA, Perez AT, Kupfer SF, Spanheimer RC, Demissie S, Fleck PR.

    Diab Vasc Dis Res. 2006 May;3(1):39-44. Erratum in: Diab Vasc Dis Res. 2006 Sep;3(2):71. PMID: 16784180 [PubMed - indexed for MEDLINE]Related articles

    13.

    Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitope.

    Alleva DG, Maki RA, Putnam AL, Robinson JM, Kipnes MS, Dandona P, Marks JB, Simmons DL, Greenbaum CJ, Jimenez RG, Conlon PJ, Gottlieb PA.

    Scand J Immunol. 2006 Jan;63(1):59-69.PMID: 16398702 [PubMed - indexed for MEDLINE]Related articles

    14.

    Striant SR: a novel, effective and convenient testosterone therapy for male hypogonadism.

    Korbonits M, Kipnes M, Grossman AB.

    Int J Clin Pract. 2004 Nov;58(11):1073-80. Review.PMID: 15605676 [PubMed - indexed for MEDLINE]Related articles

    15.

    The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.

    Fischer JS, McLaughlin T, Loza L, Beauchamp R, Schwartz S, Kipnes M.

    Curr Med Res Opin. 2004 Nov;20(11):1703-10.PMID: 15537471 [PubMed - indexed for MEDLINE]Related articles

    16.

    New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men.

    Wang C, Swerdloff R, Kipnes M, Matsumoto AM, Dobs AS, Cunningham G, Katznelson L, Weber TJ, Friedman TC, Snyder P, Levine HL.

    J Clin Endocrinol Metab. 2004 Aug;89(8):3821-9.PMID: 15292312 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Short-term pharmacokinetic comparison of a novel testosterone buccal system and a testosterone gel in testosterone deficient men.

    Dobs AS, Matsumoto AM, Wang C, Kipnes MS.

    Curr Med Res Opin. 2004 May;20(5):729-38.PMID: 15140340 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.

    Lewin AJ, Kipnes MS, Meneghini LF, Plotkin DJ, Perevozskaya IT, Shah S, Maccubbin DL, Mitchel YB, Tobert JA; Simvastatin/Thiazolidinedione Study Group.

    Clin Ther. 2004 Mar;26(3):379-89.PMID: 15110130 [PubMed - indexed for MEDLINE]Related articles

    19.

    Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension.

    Williams GH, Burgess E, Kolloch RE, Ruilope LM, Niegowska J, Kipnes MS, Roniker B, Patrick JL, Krause SL.

    Am J Cardiol. 2004 Apr 15;93(8):990-6.PMID: 15081441 [PubMed - indexed for MEDLINE]Related articles

    20.

    Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.

    Kipnes M, Dandona P, Tripathy D, Still JG, Kosutic G.

    Diabetes Care. 2003 Feb;26(2):421-6.PMID: 12547873 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Glycemic and insulinemic responses of nondiabetic healthy adult subjects to an experimental acid-induced viscosity complex incorporated into a glucose beverage.

    Wolf BW, Lai CS, Kipnes MS, Ataya DG, Wheeler KB, Zinker BA, Garleb KA, Firkins JL.

    Nutrition. 2002 Jul-Aug;18(7-8):621-6.PMID: 12093442 [PubMed - indexed for MEDLINE]Related articles

    22.

    Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.

    Kipnes MS, Krosnick A, Rendell MS, Egan JW, Mathisen AL, Schneider RL.

    Am J Med. 2001 Jul;111(1):10-7.PMID: 11448655 [PubMed - indexed for MEDLINE]Related articles

    23.

    Sugar-free zinc gluconate glycine lozenges (Cold-Eeze) do not adversely affect glucose control in patients with type 1 or type 2 diabetes mellitus.

    Schwartz SL, Fischer JS, Kipnes MS.

    Am J Ther. 2001 Jul-Aug;8(4):247-52.PMID: 11441324 [PubMed - indexed for MEDLINE]Related articles

    24.

    Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group.

    Silvers D, Kipnes M, Broadstone V, Patterson D, Quigley EM, McCallum R, Leidy NK, Farup C, Liu Y, Joslyn A.

    Clin Ther. 1998 May-Jun;20(3):438-53.PMID: 9663360 [PubMed - indexed for MEDLINE]Related articles

    25.

    Testosterone pharmacokinetics after application of an investigational transdermal system in hypogonadal men.

    Yu Z, Gupta SK, Hwang SS, Kipnes MS, Mooradian AD, Snyder PJ, Atkinson LE.

    J Clin Pharmacol. 1997 Dec;37(12):1139-45.PMID: 9506009 [PubMed - indexed for MEDLINE]Related articles

    26.

    Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients.

    Jabri N, Schalch DS, Schwartz SL, Fischer JS, Kipnes MS, Radnik BJ, Turman NJ, Marcsisin VS, Guler HP.

    Diabetes. 1994 Mar;43(3):369-74.PMID: 8314009 [PubMed - indexed for MEDLINE]Related articles

    27.

    Effects of short-term insulin therapy upon therapeutic response to glipizide.

    Schwartz SL, Fischer JS, Kipnes MS, Boyle M.

    Am J Med. 1987 Sep 18;83(3A):22-30.PMID: 3307403 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...